Affinivax

Affinivax

Next generation vaccine technology platform

Human health & social work | United States of America | Capacity Building |

 

Overview

Affinivax is developing novel vaccines based on its proprietary technology platform the Multiple Antigen Presenting System (MAPS). Working with world experts in vaccine discovery and development Affinivax is building a pipeline of innovative vaccines to achieve broader protection against a wide range of diseases including those for which there are no effective vaccines available today.

Industry

Legal Structure

Operating Status

Employees

Human health & social work Operating 2 - 10 employees

Funding and Financing Rounds


Team


Impact

Social Objectives:

Environmental Objectives:

Operational Impact:


Impact Reports & Metrics


Offices

Headquarters


Cambridge, Massachusetts United States of America



Explore

Revision History

Last Update: Oct 07, 2017 5:20 p.m.

Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


Incoming

Tags

COPYRIGHT 2019 IMPACTSPACE. ALL RIGHTS RESERVED.